FOSINOPRIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fosinopril, and what generic alternatives are available?
Fosinopril is a drug marketed by Actavis Labs Fl Inc, Apotex, Aurobindo Pharma Ltd, Chartwell Rx, Invagen Pharms, Prinston Inc, Ranbaxy Labs Ltd, Teva, Upsher Smith Labs, Watson Labs, Ani Pharms, Aurobindo Pharma, Mylan, Sandoz, and Sun Pharm Inds Ltd. and is included in twenty NDAs.
The generic ingredient in FOSINOPRIL is fosinopril sodium; hydrochlorothiazide. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the fosinopril sodium; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fosinopril
A generic version of FOSINOPRIL was approved as fosinopril sodium; hydrochlorothiazide by SANDOZ on September 28th, 2005.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FOSINOPRIL?
- What are the global sales for FOSINOPRIL?
- What is Average Wholesale Price for FOSINOPRIL?
Summary for FOSINOPRIL
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 20 |
| Drug Prices: | Drug price information for FOSINOPRIL |
| DailyMed Link: | FOSINOPRIL at DailyMed |



